PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27646854-4	2016	Guadecitabine is formulated as a dinucleotide of decitabine and deoxyguanosine that is resistant to cytidine deaminase (CDA) degradation and results in prolonged in vivo exposure to decitabine following small volume subcutaneous administration of guadecitabine.	guadecitabine	0-13	cytidine deaminase	Homo sapiens	100-118	
27646854-4	2016	Guadecitabine is formulated as a dinucleotide of decitabine and deoxyguanosine that is resistant to cytidine deaminase (CDA) degradation and results in prolonged in vivo exposure to decitabine following small volume subcutaneous administration of guadecitabine.	guadecitabine	0-13	cytidine deaminase	Homo sapiens	120-123	
27646854-11	2016	Guadecitabine, in contrast to decitabine, blocked growth in HCC cells overexpressing macroH2A1 histones and with high CDA levels, despite being unable to fully demethylate CDKN2A, RUNX3, and DLEC1 promoters altered by macroH2A1.	guadecitabine	0-13	cytidine deaminase	Homo sapiens	118-121	
26296954-2	2015	Guadecitabine (SGI-110) is a novel hypomethylating dinucleotide of decitabine and deoxyguanosine resistant to degradation by cytidine deaminase.	guadecitabine	0-13	cytidine deaminase	Homo sapiens	125-143